SCHEMBL17761485

SCHEMBL17761485

COc1cccc(C2CCc3cc(C(=O)O)ccc3O2)c1

nearest known ligand 0.48

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.48
AR P10275 1/20 0.48
ABCG2 Q9UNQ0 1/20 0.48
FFAR1 O14842 2/20 0.46
TDP1 Q9NUW8 1/20 0.45
LMNA P02545 1/20 0.45
CYP19A1 P11511 2/20 0.44
SLC8A1 P32418 7/20 0.43
MAOB P27338 1/20 0.43
GABRA1 P14867 1/20 0.42
GABRB2 P47870 1/20 0.42
ESR1 P03372 1/20 0.42
ESR2 Q92731 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
CFTR P13569 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4360502 0.83 ESR1 (0.63) ABCB1ARABCG2FFAR1LMNA
SCHEMBL2960656 0.80 LMNA (0.55) ABCB1ARABCG2FFAR1LMNA
SCHEMBL29974296 0.80 LMNA (0.55) ABCB1ARABCG2FFAR1LMNA
SCHEMBL11053487 0.79 ABCB1 (0.61) ABCB1ARABCG2CYP19A1SLC8A1
SCHEMBL22882748 0.78 FFAR1 (0.49) ABCB1ARABCG2FFAR1LMNA
SCHEMBL19230618 0.77 ESR2 (0.72) ARFFAR1TDP1CYP19A1SLC8A1
SCHEMBL19230614 0.77 ESR1 (0.50) CYP19A1SLC8A1MAOBGABRA1GABRB2
SCHEMBL16160573 0.76 ESR2 (0.63) FFAR1LMNACYP19A1ESR1ESR2
SCHEMBL17708841 0.74 ABCB1 (0.62) ABCB1ARABCG2LMNACYP19A1
SCHEMBL17708839 0.74 ABCB1 (0.62) ABCB1ARABCG2LMNACYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3212189-A1 SUBSTITUTED CHROMANES AND METHOD OF USE AbbVie S.À.R.L. (LU) 2017-09-06 EP claimed
WO-2016069757-A1 SUBSTITUTED CHROMANES AND METHOD OF USE ABBVIE INC. (US) 2016-05-06 WO claimed
EP-3212189-A1 SUBSTITUTED CHROMANES AND METHOD OF USE AbbVie S.À.R.L. (LU) 2017-09-06 EP disclosed
WO-2016069757-A1 SUBSTITUTED CHROMANES AND METHOD OF USE ABBVIE INC. (US) 2016-05-06 WO disclosed